Tekla Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Tekla Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,300	Closed	-$2.63M	–	213
2020 Q3	$2.63M	Hold	19,300	–	–	0.1%	138
2020 Q2	$1.86M	Hold	19,300	–	–	0.07%	167
2020 Q1	$905K	Hold	19,300	–	–	0.04%	180
2019 Q4	$1.41M	Hold	19,300	–	–	0.05%	167
2019 Q3	$1.01M	Sell	19,300 -19,300	-50%	-$1.03M	0.04%	158
2019 Q2	$1.94M	Hold	38,600	–	–	0.08%	136
2019 Q1	$2.01M	Hold	38,600	–	–	0.08%	131
2018 Q4	$1.89M	Hold	38,600	–	–	0.08%	135
2018 Q3	$2.52M	Buy	+38,600	New	+$2.27M	0.09%	133

Tekla Capital Management's MYOK Position: Q4 2020 in Review

Tekla Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 19,300 shares — an estimated $2.63M sold.

Tekla Capital Management first reported a position in MYOK in Q3 2018 and held it in 9 quarters. The position peaked at $2.63M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Tekla Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Tekla Capital Management sold 19,300 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.63M.
Tekla Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
Tekla Capital Management's MyoKardia, Inc. Common Stock position peaked at $2.63M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Tekla Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.